TERNS PHARMACEUTICALS INC

$9.36 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About TERNS PHARMACEUTICALS INC

Terns Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company discovers and develops molecularly-targeted and oral molecule drugs for the treatment of liver disease and cancer. Terns Pharmaceuticals serves customers worldwide.

Stock Analysis

last close $9.36
1-mo return -13.2%
3-mo return 9.3%
avg daily vol. 40.6T
52-week high 28.36
52-week low 6.92
market cap. $247M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 85.3%
baraka

Subscribe now for daily local and international financial news

Subscribe